文献速递关节外科

髋关节置换术中短干骺端负载非骨水泥股骨柄的系统综述

A systematic review of short metaphyseal loading cementless stems in hip arthroplasty.
PubMed 文献 · Bone Joint J · 2019-01-01

该系统综述纳入28项研究、5322髋(4657例患者,平均年龄59岁),评估短干骺端负载非骨水泥股骨柄行全髋关节置换的临床与影像学结果、并发症、翻修率及假体生存率。平均随访6.1年,Harris髋关节评分从46改善至92,假体生存率98.6%(平均随访12.1年),仅中期生存率已知,许多短柄长期生存率仍未知。

要点

  • 短柄股骨假体临床与影像学改善与传统长度假体相似,但仅中期生存率已知。
  • 15项研究报告假体生存率98.6%(范围92%至100%),平均随访12.1年。
  • 大量短柄假体未经分期临床试验即已商业化使用,许多长期生存率仍未知。

核心结论

  • 短柄股骨假体在临床和影像学结果上与传统长度假体显示相似改善,但仅中期生存率已知。
  • 大量短柄假体未经分期临床试验即已开发并商业化使用,许多假体长期生存率仍未知。
  • 创新与确保新假体引入受控直至安全性和患者获益得到证实的道德义务之间存在张力。
  • 假体创新及后续使用应由已证实的临床结果驱动,而非市场和财务力量,且必须确保符合伦理实践。

研究设计与样本

  • 系统综述,检索EMBASE、Medline和Cochrane数据库,采用严格纳入和排除标准筛选报告短柄髋关节置换临床和影像学随访的研究。
  • 共纳入28项研究,包括4657例患者的5322髋,平均年龄59岁(范围13至94岁),平均随访6.1年(范围0.5至20年)。

主要发现

  • 平均Harris髋关节评分从46(范围0至100)改善至92(范围39至100)。
  • 平均Oxford髋关节评分从25(范围2至42.5)改善至35(范围12.4至48)。
  • 平均Western Ontario & McMaster Universities骨关节炎指数从54(范围2至95)改善至22(范围0至98)。
  • 高达90.9%的病例组件冠状面对线为中立位。
  • 15项研究报告组件生存率,平均随访12.1年时为98.6%(范围92%至100%)。

关键数值与推荐

  • 组件冠状面中立对线率高达90.9%。
  • 15项研究报告的平均随访12.1年假体生存率为98.6%(范围92%至100%)。
  • 平均Harris髋关节评分从46改善至92,平均Oxford髋关节评分从25改善至35,平均WOMAC指数从54改善至22。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅中期生存率已知,许多短柄假体的长期生存率仍未知。
  • 大量短柄组件未经分期临床试验即已开发并商业化使用。
  • 创新与确保新假体引入受控直至安全性和患者获益得到证实的道德义务之间存在张力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Short-stemmed femoral implants have been used for total hip arthroplasty (THA) in young and active patients to conserve bone, provide physiological loading, and reduce the incidence of thigh pain. Only short- to mid-term results have been presented and there have been concerns regarding component malalignment, incorrect sizing, and subsidence. This systematic review reports clinical and radiological outcomes, complications, revision rates, and implant survival in THA using short-stemmed femoral components. MATERIALS AND METHODS: A literature review was performed using the EMBASE, Medline, and Cochrane databases. Strict inclusion and exclusion criteria were used to identify studies reporting clinical and radiological follow-up for short-stemmed hip arthroplasties. RESULTS: A total of 28 studies were eligible for inclusion. This included 5322 hips in 4657 patients with a mean age of 59 years (13 to 94). The mean follow-up was 6.1 years (0.5 to 20). The mean Harris Hip Score improved from 46 (0 to 100) to 92 (39 to 100). The mean Oxford Hip Score improved from 25 (2 to 42.5) to 35 (12.4 to 48). The mean Western Ontario & McMaster Universities Osteoarthritis Index improved from 54 (2 to 95) to 22 (0 to 98). Components were aligned in a neutral coronal alignment in up to 90.9% of cases. A total of 15 studies reported component survivorship, which was 98.6% (92% to 100%) at a mean follow-up of 12.1 years. CONCLUSION: Short-stemmed femoral implants show similar improvement in clinical and radiological outcomes compared with conventional length implants. Only mid-term survivorship, however, is known. An abundance of short components have been developed and used commercially without staged clinical trials. Long-term survival is still unknown for many of these components. There remains tension between innovation and the moral duty to ensure that the introduction of new implants is controlled until safety and patient benefit are demonstrated. Implant innovation and subsequent use should be driven by proven clinical outcomes, rather than market and financial forces, and ethical practice must be ensured. Cite this article: Bone Joint J 2019;101-B:502-511.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Lidder S, Epstein DJ, Scott G, et al. A systematic review of short metaphyseal loading cementless stems in hip arthroplasty. Bone Joint J. 2019. PMID: 31037973. doi:10.1302/0301-620X.101B5.BJJ-2018-1199.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。